The currently used biomarker, PSA (prostate specific antigen) measured from blood, cannot reliably confirm the presence of cancer in the prostate since increased levels are frequently found also in other prostatic diseases such as hyperplasia and prostatitis. This evidence concerns the gene KLK3 and prostatitis.